Big Pharma Exploring Targeted MS to Measure Key Transporter Proteins for Drug Development
August 12, 2011
Big Pharma Exploring Targeted MS to Measure Key Transporter Proteins for Drug Development
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Tohoku U Spinoff Targeting Pharma Industry with SRM-MS Assays for ADMET Research
August 5, 2011 / ProteoMonitor - Hutch, Broad Teams Publish Comprehensive Methods for MS-Based Biomarker Discovery and Verification
July 29, 2011 / ProteoMonitor - Protein Biomarkers for Alzheimer's Predicted to Represent Cumulative $9B Market Over Next Decade
June 3, 2011 / ProteoMonitor - Yale Researcher Suggests More Focus on EGFR Isoforms Needed in Development of Antibody-Based Drugs
May 20, 2011 / ProteoMonitor - 26,000-Patient Study Suggests Triple-Biomarker Approach Could Improve CKD Diagnosis
April 29, 2011 / ProteoMonitor